KLF5 is also a mediator of the inhibitory effects of the TGF-β signaling on cancer that TGF-β/SMAD4 signal inhibits the transcription of KLF5 that, in turn, switches Sox4 from tumor promoter to suppressor (92). The gene discussed is KLF5; the disease is neoplasm.